Dylan’s bedaquline paper one of the most read in Microbial Genomics in September! Philip Fowler, 20th October 202520th October 2025 Received a lovely email from Dr Peter Cotgreave who is the Chief Executive of the Microbiological Society to say Dylan’s manuscript where he created a resistance catalogue for bedaquiline was one of the most viewed papers in Microbial Genomics during September. Never had that before, but a nice surprise! Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Related publication research tuberculosis
antimicrobial resistance New publication: how quickly can be calculate the effect of a mutation on an antibiotic? 20th November 202020th November 2020 The idea for this paper arose during talking over coffee at the BioExcel Alchemical Free… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More
New publication: CRyPTIC GWAS of antitubercular resistance 16th August 202216th August 2022 Since the primary goal of CRyPTIC was to map the genetic variants in M. tuberculosis… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More
antimicrobial resistance BashTheBug.net Beta Testing Results 5th April 20175th August 2018 Zooniverse have finished beta-testing my BashTheBug citizen science project. To verify that the task is… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More